The articles provided by the AHEC research staff have been valuable in helping my colleagues achieve credibility for our novel therapeutic in treating nearly moribund patients at the onset of the pandemic viral disorder known as COVID-19. This was esp relevant when there were NO therapies other than supportive ICU care. The AHEC articles requested led us to a team of pre-clinical researchers half-way around the world who were willing and able to incorporate our novel therapeutic concepts into their own molecular and immunological experiments to document what we observed clinically. The unique experimental discoveries provided credence for therapeutic concepts given consistently positive clinical outcomes. We credit the AHEC staff for having the expertise to sort through seemingly relevant published information as they were able to discern between AI hallucinations and reality. In essence, their contributions have identified that AI research remains in its infancy with significant limitations esp relevant during the timeframe of February 2020 to June 2025. Our own publications have acquired achieved an authenticity not otherwise acquired had we relied solely on machine learning, i.e. AI.